Osteoporosis management: Physicians' recommendations and womens' compliance following osteoporosis testing

Women and Health

Volumn 29, Issue 1, 1999, Pages 101-115

  Cole, Robert P ^b   Palushock, Sharon ^a   Haboubi, Ayad ^c  

^a Lackawanna Medical Group   (United States)

^b All Serv Rehabilitation Hospital   (United States)

^c NONE

Author keywords

Bone mineral density; Compliance; Fracture risk; Osteoporosis; Treatment

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; VITAMIN D;

ADULT; AGE; AGED; ARTICLE; BONE MASS; FEMALE; FEMUR NECK; FRACTURE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATIENT COMPLIANCE; RISK;

AGED; ALENDRONATE; ANALYSIS OF VARIANCE; BONE DENSITY; CALCITONIN; CALCIUM; DENSITOMETRY, X-RAY; DRUG UTILIZATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; VITAMIN D;

EID: 0032856702     PISSN: 03630242     EISSN: None     Source Type: Journal    
DOI: 10.1300/J013v29n01_08     Document Type: Article

References (30)

1. nd ed.: pp. 351-370). Philadelphia: Lippincott-Raven.
2. nd Edition; pp. 391-401). Philadelphia, PA: Lippincott-Raven.
3. Civitelli, R., Gonnelli, S., Zacchei, F., Bigazzi, S., Vattimo, A., Avioli, L. V., & Gennari, C. (1988). Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. Journal of Clinical Investigation, 82, 1268-1274.
4. Harris, S.T., Gertz, B.J., Genant, H.K., Eyre, D.R., Survill, T.T., Ventura, J.N., De-Brock, J., Ricerca, E., & Chesnut, C.H. (1993). The effect of short-term treatment with alendronate on vertebral density and biochemical markers of bone remodeling in early postmenopausal women. Journal of Clinical Endocrinology and Metabolism, 76, 1399-1406.
5. Jones, M.M., Francis, R.M., & Nordin, B.E.C. (1982). Five-year follow-up of oestrogen therapy in 94 women. Maturitas, 3, 123.
6. Kanis, J.A., Johnell, O., Gullberg, B., Allander, E., Dilsen, G., Gennari, C., Lopes Vaz, A.A., Lyritis, G.P., Mazzuoli, G., Miravet, L., Passeri, M., Cano, R.P., Rapado, A., & Ribot, C. (1992). Evidence for efficacy of drugs effecting bone metabolism in preventing hip fracture. British Medical Journal, 305, 1124-1128.
7. Lufkin, E.G., Wahner, H.W., O'Fallon, W.M., Hudson, J.F., Kotowitz, M.A., Lane, A.W., Judd, H.L., Caplan, R.H., & Riggs, B.L. (1992). Treatment of postmenopausal osteoporosis with transdermal estrogen. Annals of Internal Medicine, 117, 1-9.
8. Marottoli, R.A., Berkman, L.F., & Cooney, L.M., Jr. (1992). Decline in physical function following hip fracture. Journal of the American Geriatric Society, 40, 861-866.
9. nd Edition; pp. 225-248). Philadelphia, PA: Lippincott-Raven.
10. Melton, L.J., III., Thamer, M., Ray, N.F., Chan. J.K., Chesnut, C.H., III., Einhorn, T.A., Johnston, C.C., Raisz, L.G., Silverman, S.L., & Siris, E.S. (1997). Fractures attributable to osteoporosis: Report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research, 12, 16-23.
11. Nordin, B.E.C., Horsman, A., & Marshall, D.H. (1979). Calcium requirement and calcium therapy. Clinical Orthopedics, 140, 216-239.
12. Nordin, B.E.C., Horsman, A., Crilly, R.G., Marshall, D.H., & Simpson, M. (1980). Treatment of spinal osteoporosis in postmenopausal women. British Medical Journal, 280, 451-454.
13. Office of Technology Assessment, Congress of the United States. (1994). Hip fracture outcomes in people age fifty and over: Background paper. U.S. Government Printing Office, Washington, DC.
14. 3. Bone and Mineral, 3, 47-52.
15. Overgaard, K. (1994). Effect of intranasal calcitonin therapy on bone mass and bone turnover in early postmenopausal women: A dose-response study. Calcified Tissue International, 55, 82-86.
16. Overgaard, K., Hansen, M.A., Jensen, S.B., & Christiansen, C. (1992). Effect of salcatonin given intramuscularly on bone mass and fracture in rats in established osteoporosis: A dose response study. British Medical Journal, 305, 74-79.
17. Ravnikar, V.A. (1987). Compliance with hormone therapy. American Journal of Obstetrics and Gynecology, 156, 1332-1334.
18. Ray, N.F., Chan, J.K., Thamer, M., & Melton, L.J., III. (1997). Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation. Journal of Bone and Mineral Research, 12, 24-35.
19. Riggs, L.B., & Melton, L.J., III. (1992). The prevention and treatment of osteoporosis. New England Journal of Medicine, 327, 620-627.
20. nd ed.). Philadelphia: Lippincott-Raven.
21. Riis, B., Thomsen, K., & Christiansen, C. (1987). Does calcium supplementation prevent postmenopausal bone loss? New England Journal of Medicine, 316, 173-177.
22. Rubin, S.M., & Cummings, S.R. (1992). Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Annals of Internal Medicine, 116, 990-995.
23. 3. Clinical Endocrinology, 7, 169S-175S.
24. Stevenson, J.C., Cust, M.P., & Ganger, K.F. (1990). Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet, 336, 265-269.
25. Tucci, J.R., Tonino, R.P., Emkey, R.D., Peverly, C.A., Kher, U., & Santora, A.C. (1996). Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. American Journal of Medicine, 101, 488-501.
26. Wallace, W.A., Price, V.H., Elliot, C.A., MacPherson, M.B., & Scott, B.W. (1990). Hormone replacement therapy acceptability to Nottingham postmenopausal women with a risk factor for osteoporosis. Journal of the Royal Society of Medicine, 83, 699-701.
27. Wasnich, R.D., Ross, P.D., Heilbrun, L.K., & Vogel, J.M. (1985). Prediction of postmenopausal fracture risk with use of bone mineral measurements. American Journal of Obstetrics and Gynecology, 153, 745-751.
28. World Health Organization. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Report of a WHO study group. (Technical report series 843).
29. Wright, R.E. (1995). Logistic Regression. In L.G. Grimm & P.R. Yarnold (Eds.), Reading and understanding multivariate statistics (pp. 217-244). Washington, DC: American Psychological Association.
30. Zeil, H.K., & Finkle, W.D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogens. New England Journal of Medicine, 293, 1167-1170.